The company
SELLAS Life Sciences Group, Inc.
SLS · Nasdaq
SLS stood above a rising 150-day average in 48 of the last 52 weekly readings, including each of the last 46 weeks. It is 9.9% above that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 46 in a row
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $101K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 182 (+34)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 48 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 15,070,302$222.4M | +2,871,892+23.5% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 12,996,558$191.8M | +4,600,202+54.8% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 8,226,105$121.4M | +700,176+9.3% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 4,884,175$72.1M | +971,569+24.8% |
| Anson Funds Management LPnew · filed 13 Aug 2026 | 4,500,000$66.4M | +4,500,000 |
| JONES FINANCIAL COMPANIES LLLPadded · filed 14 Aug 2026 | 2,304,561$28.6M | +629,484+37.6% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,161,099$31.9M | +698,293+47.7% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPadded · filed 14 Aug 2026 | 2,050,597$30.3M | +1,653,541+416.5% |
| NORTHERN TRUST CORPadded · filed 13 Aug 2026 | 1,619,928$23.9M | +343,944+27.0% |
| VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026 | 1,335,166$19.7M | +132,327+11.0% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.